Press Release
Leading real-world data and analytics organizations form industry coalition to advance policies to support regulatory use of real-world evidence
Washington, D.C. (May 19, 2021) – Five real-world data (RWD) and analytics organizations ...
News
Aetion hauls in $110M Series C to fuel global growth in real-world evidence space
Fierce Healthcare reports that Aetion, which offers real-world evidence and analytics to ...
News
Aetion doubles lifetime funding with $110M series C for real-world data platform
Fierce Biotech reports in 2021 that Aetion, a real-world evidence platform, has secured ...
News
Real-world evidence startup Aetion lands $110M in Series C as it looks toward global expansion
Aetion, a tech startup focused on real-world evidence in healthcare, landed $110 million ...
News
RWE upstart maps a new global plan as investors pour in the latest mega-round
As regulators continue to rely more on real world evidence, New York-based RWE leader ...
Press Release
Aetion closes $110M Series C funding round led by Warburg Pincus
BOSTON and NEW YORK, May 11, 2021 – Health care technology company Aetion announced today ...
News
ICER pilot project to use real-world evidence in hereditary angioedema treatments value assessment update
Evidence Base Online reports The Institute for Clinical and Economic Review (ICER; MA, ...
News
ICER to incorporate RWE into assessment of HAE drugs
The US Institute for Clinical and Economic Review (ICER) has announced that it is using ...
News
ICER launches pilot program to update past assessments using real-world data
Jazz Pharmaceuticals has received priority review from the FDA for expanding the use of ...
News
Accelerated approval, real-world evidence pilot from ICER, Aetion picks HAE as first therapeutic area
ICER signals how it will pick other therapies for pilot in an interview with Pink Sheet. ...
Press Release
ICER to use Aetion observational RWE to update value assessment of treatments for hereditary angioedema
New ICER pilot will incorporate more than 24 months of observational real-world ...
News
Coronavirus infection leads to immunity that’s comparable to a COVID-19 vaccine
One of the enduring questions of the COVID-19 pandemic is how much immunity people are ...
News
COVID-19 antibodies may protect against reinfection later, study suggests
A study published in the journal JAMA Internal Medicine found that people who tested ...
Press Release
Replica Analytics Announces New Funding from Nina Capital
Replica Analytics has closed a financing round with Nina Capital. This new funding ...
News
Aetion: Fierce 15 Awards 2021
Amidst unprecedented challenges, adaptability emerged as a key determinant of success for ...
News
SARS-CoV-2 antibodies can protect from reinfection, NCI study suggests
As COVID-19 vaccines start to roll out in the US, research led by the National Cancer ...
Press Release
First RCT-DUPLICATE findings published in Circulation
NEW YORK, December 17, 2020 — Real-world evidence (RWE) studies can offer comparable ...
News
Her Story podcast: Fitting the pieces together with Carolyn Magill
This podcast episode features an interview with Carolyn Magill, the CEO of Aetion, a ...
News
‘Unpredictable pathogen’: New coronavirus study highlights severity of illness
While COVID-19 is commonly associated with symptoms like a loss of smell or taste, a new ...
Press Release
Replica Analytics Data Synthesis Platform Launched to Support Data Transparency and Data Science Globally
Replica Analytics Ltd., a leading provider of privacy protective synthetic data, is proud ...
Press Release
FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund
Replica Analytics and Sunnybrook’s Czarnota Lab receive key seed funding to de-risk ...
Press Release
New Funding for Data Synthesis Innovations
Replica Analytics Receives over $1 Million in New Funding for Data Synthesis Innovations ...
Press Release
First Synthetic Health Dataset in Province
Alberta Project Validates First Synthetic Health Dataset in Province Read more
Press Release
Aetion statement on UCSF-led study to inform drug development for COVID-19, future pandemics
NEW YORK, October 15, 2020 — Aetion co-authored a study published today in Science, which ...